Prescription drug · ANDA
Dimenhydrinate NDC 63323-366
Dimenhydrinate 50 mg/mL · Injection, Solution · Intramuscular, Intravenous · Fresenius Kabi USA, LLC
NDC codes
FDA NDC Directory| Package NDC | 11-digit (billing) | Package | Copy |
|---|---|---|---|
| 63323-366-01 | 63323036601 | 25 VIAL in 1 TRAY (63323-366-01) / 1 mL in 1 VIAL (63323-366-00)Marketed from Nov 29, 2004 |
How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules
Product information
- Brand name (proprietary)
- Dimenhydrinate
- Generic name (nonproprietary)
- dimenhydrinate
- Active ingredients
- Dimenhydrinate — 50 mg/mL
- Dosage form
- Injection, Solution
- Route
- Intramuscular, Intravenous
- Labeler
- Fresenius Kabi USA, LLC
- Product type
- Prescription drug
- Marketing category
- ANDA — Abbreviated New Drug Application (generic)Application ANDA 040519
- Marketing start
- Listing expires
- Identifiers
- Product ID 63323-366_b3e3433d-c18b-4ed3-b2ba-1e550474ca33SPL ID b3e3433d-c18b-4ed3-b2ba-1e550474ca33SPL set ID bc71539e-1a33-4709-8a24-c2894e8dbc1cRxCUI 309914UNII JB937PER5CUPC 0363323366001
Billing references
What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.
- HCPCS codeNo match
No drug-specific HCPCS code in Med-Code's directory for this product. The directory is curated and not complete — check the current CMS HCPCS file before billing.
- Administration
Drug administration (CPT 96360–96549)
When a clinician administers the drug, the administration is reported separately. Codes in this range cover hydration, therapeutic injections and infusions, and chemotherapy or other complex drug administration. The right code depends on route, duration and drug type, and self-administered drugs are not billed this way.
- NDC on a medical claim
N463323036601followed by a unit qualifier and the quantityPackage 63323-0366-01. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier
Product label
Current FDA label (SPL), effective .
Indications (excerpt from the label)
INDICATIONS AND USAGE Dimenhydrinate Injection, USP is indicated for the prevention and treatment of nausea, vomiting, or vertigo of motion sickness.
Excerpt only. Read the full label for complete information.